Tuesday, December 1, 2020

admin

848 POSTS2 COMMENTS

FDA clearance for HealthLytix for breakthrough prostate imaging solution, RSI-MRI+

Nov 26, 2019:  HealthLytix, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its breakthrough prostate...

USFDA Approved Silodosin Capsules, 4 mg and 8 mg for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH)

Nov 25, 2019: Alembic Pharmaceuticals  Abbreviated New Drug Application (ANDA) Silodosin Capsules, 4 mg and 8 mg approved by US Food &...

Healx commits $20M to launch Rare Treatment Accelerator programme that focus on finding new treatments for rare diseases

Nov 26, 2019: Healx’s Applications are now being accepted for its Rare Treatment Accelerator (RTA), new programme that focus on finding new treatments for...

KEYTRUDA, Merck’s anti-PD-1 therapy Now Approved by the National Medical Products Administration in China for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer...

Nov 26, 2019: Merck announced that KEYTRUDA (Merck’s anti-PD-1 therapy) in combination with carboplatin and paclitaxel for the first-line treatment of patients...

Tonix Pharmaceuticals Announces Tonmya® (cyclobenzaprine) as a Potential New Treatment for posttraumatic stress disorder (PTSD)

Nov 26, 2019: Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company announced that from the Clinical Guidance meeting with the U.S. Food and Drug...

California-based food manufacturer agrees to stop production after repeated food safety violations

Nov 26, 2019: After several inspections conducted by the FDA, Golden Gate Soy Products, a California-based food manufacturer agreed to stop the...

U.S. Food and Drug Administration issued warning letters to 15 companies Including Several In California for illegally selling products containing cannabidiol (CBD) in ways...

Nov 25, 2019: 15 companies Including Several In California received warning letters by  the U.S. Food and Drug Administration for illegally selling...

15 Companies received warning letter by U.S. Food and Drug Administration for illegally selling products containing cannabidiol as agency details safety concerns

Nov 25, 2019: 15 Companies received warning letter by U.S. Food and Drug Administration the for illegally selling products containing cannabidiol that...

Oxbryta (voxelotor) approved by U.S. Food and Drug Administration for the treatment of sickle cell disease (SCD)

Nov 25, 2019 Oxbryta (voxelotor)approved by  the U.S. Food and Drug Administration  for the treatment of sickle cell disease (SCD) in adults...

The first oral small molecule targeting splicing Risdiplam approved by US FDA for the treatment of spinal muscular atrophy

Nov 25, 2019: PTC Therapeutics, Inc announced that the United States Food and Drug Administration (FDA) has granted priority review for the...

Vaccitech announces successful recruitment and vaccination for two phase 2 Universal influenza studies FLU009 and FLU010 for the treatment and prevention of cancer...

Nov 25, 2019: Vaccitech Ltd, a clinical-stage T cell immunotherapy company develop the products for the treatment and prevention of  cancer and infectious...

FDA approves new system for the delivery of tympanostomy tubes under local anesthesia to treat ear infection

Nov 25, 2019 :Tusker Medical recievied approval from The U.S. Food and Drug Administration for the delivery of tympanostomy tubes (ear tubes)...

TOP AUTHORS

848 POSTS2 COMMENTS

Most Read

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

November 30, 2020: Eisai and Wren Therapeutics announced that the companies have entered into an exclusive research collaboration agreement aiming to advance...

AstraZeneca agreed to sell rights to Crestor to be divested to Grünenthal in Europe

December 01, 2020: AstraZeneca has agreed to sell the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe, except the...

AstraZeneca’sForxiga approved in Japan for chronic heart failure

November 30, 2020: AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving...

Moderna Announces the EC Approval for Initial 80 Million Doses of mRNA Vaccine Against COVID-19

November 25, 2020: "Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines...